About 1 out of every 3 COVID-19 cases reported daily in the world is currently in India, which is growing faster than other infections.
The second outbreak of COVID-19 infections in India has flooded the country’s medical infrastructure as families have been begging for oxygen and other life-saving supplies on social media.
In the capital, New Delhi, corpses are being used to disperse the bodies of Kovid victims. In some hospitals, there is no ventilation, and patients are waiting outside in ambulances.
They are also working hard to help with supply issues, including volunteers Indian Care, A community of more than 3,000 people who use everything from blood donors to oxygen and medicine to social media.
Mohd Sakib, a 23-year-old student who recently joined the organization, told BuzzFeed News that daily calls are increasing day by day.
“We are losing our families in India every day,” Sakib said. “When he became a man [makes a] Question and after a while we know there is no one, this moment is much worse.
At an emergency meeting chaired by Indian Prime Minister Narendra Modi, officials agreed to meet the urgent need for oxygen for industrial purposes and to use the country’s transport network to deliver the supplies to the most demanding states.
Modi also called on states to take stronger action on supply chain.
In the first year of the epidemic, India escaped the worst of Covide-19. Although the country is the fourth deadliest country in the world behind the United States, Brazil, and Mexico, the death toll is lower than the 1.4 billion people. And as India enters 2021, it appears to be on the rise due to a sharp drop in cases and deaths in September.
However, since March, the country has seen an outbreak of a new strain of the coronavirus, B.1.617. According to the National Institute of Virology of India, this variant took the lead in broadcasts last week with about 61% of cases tested in one district. It is sometimes called a “double variable” because it contains two mutations associated with a corresponding increase. Its role in the Indian epidemic is unclear, as medical examinations are limited.
Currently, about 1 in 3 of COVID-19 cases worldwide are in India, and the incidence of new infections is growing faster than any other nation. Every day, about 2,000 people associated with Kovid are registered there, which is approximately the sixth largest in the world. However, analysis by the Financial Times on corpses shows that the number of COVID-19 deaths in India is not officially counted.
As the health system is on the verge of collapse, Girihar R. Bababu, an epidemiologist with the Indian Public Health Foundation (PHFI), warns that this will not be “the last wave and the last epidemic.”
In an interview with local media, Babu said the current situation in India should be of international concern.
“In some parts of the world, if disease control is neglected, everyone else is at risk,” he said. As immunization coverage expands, we need to closely and carefully examine the situation in the country.
To identify the epidemic, there must be strong public health management and resources to build residential systems, including the COVID-19 epidemic and genomic monitoring. It is unrealistic to expect real success in strengthening the health system, especially in terms of manpower recruitment and capacity building.
India’s situation has been partially blamed on the government, with critics including the president of PHFI accusing the Modi administration of prematurely overcoming the virus when it needed to step up efforts to strengthen the country’s medical infrastructure.
Instead, Indian election officials announced key elections in five states, the country’s cricket board gave the green light for an international stadium filled with spectators, and the Kumbo Mela Hindu Festival brought millions to Haridwa for the holy month.
The escalation of India’s CVD-19 crisis is bad news for the global effort to vaccinate people against the virus. The Indian Serum Institute in Unne is the world’s largest vaccine manufacturer and has been commissioned to produce 200 million doses of the COVAX Oxford / AstraZeneca vaccine, the World Health Organization, the Coalition for Epidemiological Innovation and Gavi, a vaccine vaccine for developing countries.
But India’s domestic vaccine release has struggled, with currently only 1.4% of the total population of COVID-19. In late March, India stopped exporting AstraZeneca vaccine supplies to its own vaccine drive.
After being approved by the Indian Serum Institute, it signed an agreement to produce nearly one billion doses of the coronavirus vaccine developed by the US company Novavax. Therefore, there will be further pressure from around the world to increase the country’s immunization program by using its immunization capacity. India has also argued that US export controls on the raw materials used to produce the vaccine are hampering its ability to meet international demand.
The USA is under pressure to donate nearly 20 million unused AstraZeneca vaccines, which have not yet been approved by the FDA. Although the United States agreed to send $ 4 million to Canada and Mexico in March, Astrazeneka said it would soon receive $ 30 million. Asked about those AstraZeneca shares, White House COVID-19 Response Coordinator Jeff Zeins said on Friday that “as confidence in our own supply grows, the United States is” exploring “options for sending over-the-counter vaccines. President Joe Biden has pledged $ 4 billion to COVAX in February as an indication of the country’s support for international immunization.
Meanwhile, the CDC is providing technical support in consultation with Indian health authorities, said Anthony Faussi, head of the National Institute of Allergies and Infectious Diseases.
“In any case, we are trying to help,” he said. “Obviously, they have to vaccinate their people.”